ABOUT
TECHNOLOGY
PIPELINE
NEWS
INVESTORS
OVERVIEW
FINANCIAL INFORMATION
PRESENTATIONS
CORPORATE GOVERNANCE
Conference presentations
2 June 2020
Phase I dose escalation study of immunoconjugate L-DOS47
ABOUT
TECHNOLOGY
PIPELINE
NEWS
INVESTORS
OVERVIEW
FINANCIAL INFORMATION
PRESENTATIONS
CORPORATE GOVERNANCE